Many believe that for every problem nature gives us, it also offers a solution. Consequently, plants have been used for medicinal purposes since the beginning of civilization. Ancient texts such as the Ebers Papyrus, Pen T’Sao, and even the Bible contain descriptions of healing properties pertaining to certain plants and herbs. In the current age, modern technologies have enabled scientists to thoroughly investigate the medicinal value of plants. For example, researchers at the University of British Columbia Okanagan have put this theory to the test , uncovering how plants produce mitraphylline — a rare natural substance that shows cancer fighting potential.

Deep in the humid rainforests of Central and South America, extremely small trace amounts of mitraphylline are found inside tropical trees such as Mitragyna (kratom) and Uncaria (cat's claw). From a biological perspective, mitraphylline is a part of a unique group of plant chemicals called spirooxindole alkaloids . Its chemical structure is characterized by a scaffold of an oxindole ring, which shares an atom with a heterocyclic moiety (a compound that contains an atom other than carbon). This complex and unique structure is what makes mitraphylline such a powerful biological tool against the formation of tumors, which are characterized by cell proliferation and heavily involved in cancer.

Mitraphylline has been shown in in vitro and in vivo studies to inhibit tumor cell proliferation by interfering with cell-cycle progression and inducing apoptosis in several cancer models, including leukemia and breast cancer cell lines. The rigid three-dimensional spiro scaffold allows mitraphylline to bind selectively to protein targets involved in signaling pathways that regulate uncontrolled cell division, giving it measurable antiproliferative and anti-inflammatory effects.

Why has this tool remained under-utilized? In truth, scientists were missing a key piece of the puzzle: the enzymes responsible for constructing mitraphylline. Enzymes are biological catalysts, usually proteins, that speed up chemical responses in living organisms. Without knowing the specific enzymes that shape mitraphylline, the natural process for building this complex chemical is impossible to replicate. Undeterred, Thu-Thuy Dang and her team at UBC Okanagan pinpointed that the cytochrome P450 enzyme is capable of forming mitraphylline’s characteristic spiro shape . To investigate this further, doctoral student Tuan-Anh Nguyen discovered two key enzymes that finalize the three-dimensional structure of mitraphylline. The first enzyme, ajmalicine epimerase, establishes the chemical’s three-dimensional configuration to set up the correct 3D shape of the precursor molecules. The second enzyme, spirooxindole synthase, was discovered to complete the final twist to turn those precursors formed by ajmalicine into the spiro-shaped structure.

The UBC scientists’ collective discovery has opened a whole new world of plant-based pharmaceuticals. Scientists now have a blueprint to recreate and remodel mitraphylline in the lab — meaning they can produce the rare compound in more scalable ways to investigate how the compound interacts with cancer cells. Discoveries like these are a part of a broader wave of research into botanical and plant derived drugs. Modern technologies like gene editing and metabolomics are helping map biosynthetic pathways to discover new biologically potent molecules. From ancient texts to modern laboratories, plants have long been woven into humanity’s search for healing. As scientists continue to uncover the molecular logic behind nature’s chemistry, compounds like mitraphylline serve as a reminder that the solutions we seek may already exist; quietly growing, waiting to be understood.